Susan Altschuller

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Somerville, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Chandra Adams, as Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Susan Altschuller

Form 4 holding SVP AND CFO

ImmunoGen, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
123,750
Estimated value
$564,300
Report date
14 Nov 2022
Price
$4.56
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Mural Oncology plc

Security class
Ordinary Shares
Shares / value
10,000
Estimated value
$32,071
Report date
14 Aug 2024
Price
$3.21
Ownership
Direct
Form 4 holding Director

Mural Oncology plc

Security class
Stock Option (right to buy)
Shares / value
8,462
Estimated value
$28,348
Report date
30 May 2024
Price
$3.35
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
Form 4 holding Chief Financial Officer

Cerevel Therapeutics Holdings, Inc.

Security class
Restricted Stock Units
Shares / value
0
Estimated value
$0
Report date
01 Aug 2024
Price
$41.18
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Financial Officer

Climb Bio, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
142,500
Estimated value
Report date
06 Jan 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Financial Officer

Cerevel Therapeutics Holdings, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
01 Aug 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Susan Altschuller

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .